Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 5
1964 10
1965 6
1966 15
1967 16
1968 23
1969 18
1970 15
1971 16
1972 22
1973 20
1974 20
1975 11
1976 16
1977 9
1978 21
1979 24
1980 24
1981 15
1982 14
1983 21
1984 10
1985 15
1986 21
1987 32
1988 46
1989 57
1990 59
1991 45
1992 71
1993 71
1994 68
1995 75
1996 104
1997 100
1998 101
1999 136
2000 118
2001 144
2002 130
2003 128
2004 152
2005 162
2006 145
2007 160
2008 220
2009 179
2010 148
2011 210
2012 196
2013 246
2014 224
2015 281
2016 299
2017 289
2018 271
2019 254
2020 255
2021 286
2022 281
2023 286
2024 94

Text availability

Article attribute

Article type

Publication date

Search Results

5,896 results

Results by year

Filters applied: . Clear all
Page 1
Pathophysiology and management of glaucoma and ocular hypertension related to trauma.
Razeghinejad R, Lin MM, Lee D, Katz LJ, Myers JS. Razeghinejad R, et al. Surv Ophthalmol. 2020 Sep-Oct;65(5):530-547. doi: 10.1016/j.survophthal.2020.02.003. Epub 2020 Feb 11. Surv Ophthalmol. 2020. PMID: 32057763 Review.
Ocular trauma is a significant cause of blindness worldwide, particularly if associated with glaucoma. ...
Ocular trauma is a significant cause of blindness worldwide, particularly if associated with glaucoma. ...
Alcohol, Intraocular Pressure, and Open-Angle Glaucoma: A Systematic Review and Meta-analysis.
Stuart KV, Madjedi K, Luben RN, Chua SYL, Warwick AN, Chia M, Pasquale LR, Wiggs JL, Kang JH, Hysi PG, Tran JH, Foster PJ, Khawaja AP; Modifiable Risk Factors for Glaucoma Collaboration. Stuart KV, et al. Ophthalmology. 2022 Jun;129(6):637-652. doi: 10.1016/j.ophtha.2022.01.023. Epub 2022 Jan 31. Ophthalmology. 2022. PMID: 35101531 Free PMC article. Review.
Evidence from 10 studies reporting an association with IOP suggests that habitual alcohol use is associated with higher IOP and prevalence of ocular hypertension (IOP > 21 mmHg), although absolute effect sizes were small. ...
Evidence from 10 studies reporting an association with IOP suggests that habitual alcohol use is associated with higher IOP and prevalence o …
Current intravitreal therapy and ocular hypertension: A review.
Sudhalkar A, Bilgic A, Vasavada S, Kodjikian L, Mathis T, de Ribot FM, Papakostas T, Vasavada V, Vasavada V, Srivastava S, Bhojwani D, Ghia P, Sudhalkar A. Sudhalkar A, et al. Indian J Ophthalmol. 2021 Feb;69(2):236-243. doi: 10.4103/ijo.IJO_1028_20. Indian J Ophthalmol. 2021. PMID: 33463565 Free PMC article. Review.
However, some studies demonstrated RNFL thinning in patients receiving chronic anti-VEGF therapy. Most, if not all, intravitreal agents cause ocular hypertension, both in the short term and long term. The functional consequences of these observations are not very cl …
However, some studies demonstrated RNFL thinning in patients receiving chronic anti-VEGF therapy. Most, if not all, intravitreal agents caus …
OCULAR HYPERTENSION AND GLAUCOMA FOLLOWING VITRECTOMY: A Systematic Review.
Miele A, Govetto A, Fumagalli C, Donati S, Biagini I, Azzolini C, Rizzo S, Virgili G. Miele A, et al. Retina. 2018 May;38(5):883-890. doi: 10.1097/IAE.0000000000001651. Retina. 2018. PMID: 28426628 Review.
PURPOSE: Pars plana vitrectomy has been reported to increase the risk of ocular hypertension and open-angle glaucoma. The authors conducted a systematic review of randomized and nonrandomized studies to compare the incidence of open-angle glaucoma and ocular
PURPOSE: Pars plana vitrectomy has been reported to increase the risk of ocular hypertension and open-angle glaucoma. The auth …
Glaucoma.
Shah R, Wormald RP. Shah R, et al. BMJ Clin Evid. 2011 Jun 9;2011:0703. BMJ Clin Evid. 2011. PMID: 21658300 Free PMC article. Review.
METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of treatments for established primary open-angle glaucoma, ocular hypertension, or both? What are the effects of lowering intraocular pr …
METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of treatme …
Intravitreal triamcinolone.
Tao Y, Jonas JB. Tao Y, et al. Ophthalmologica. 2011;225(1):1-20. doi: 10.1159/000317909. Epub 2010 Aug 7. Ophthalmologica. 2011. PMID: 20693817 Free article. Review.
Due to its properties as a long-acting steroid, triamcinolone has still been used for various conditions such as diffuse diabetic macular edema, retinal vein occlusions, pseudophakic cystoid macular edema, chronic prephthisical ocular hypotony and uveitis, and in combinati …
Due to its properties as a long-acting steroid, triamcinolone has still been used for various conditions such as diffuse diabetic macular ed …
Electrophysiology in Glaucoma.
Senger C, Moreto R, Watanabe SES, Matos AG, Paula JS. Senger C, et al. J Glaucoma. 2020 Feb;29(2):147-153. doi: 10.1097/IJG.0000000000001422. J Glaucoma. 2020. PMID: 31809397 Review.
METHODS: A systematic review of the literature was carried out by 2 independent reviewers using the PubMed and EMBASE electronic databases, searching for articles published in English from January 1, 2014 to July 1, 2019 using a combination of the following keywords: ("glaucoma" …
METHODS: A systematic review of the literature was carried out by 2 independent reviewers using the PubMed and EMBASE electronic databases, …
Netarsudil for the Treatment of Open-Angle Glaucoma and Ocular Hypertension: A Literature Review.
Gonzalez LE, Boylan PM. Gonzalez LE, et al. Ann Pharmacother. 2021 Aug;55(8):1025-1036. doi: 10.1177/1060028020971215. Epub 2020 Nov 4. Ann Pharmacother. 2021. PMID: 33148002 Review.
OBJECTIVE: To evaluate netarsudil's role as first-line therapy for the treatment of open-angle glaucoma (OAG) and ocular hypertension (OHT). DATA SOURCES: A literature search utilizing MEDLINE and CINAHL was performed using netarsudil and AR-13324 as keywords. ...
OBJECTIVE: To evaluate netarsudil's role as first-line therapy for the treatment of open-angle glaucoma (OAG) and ocular hypertens
5,896 results